{
  "drug_name": "Sucralfate",
  "url": "https://wikem.org/wiki/Sucralfate",
  "scraped_at": "2026-01-10T08:02:53.330308",
  "sections": {
    "Administration": {
      "text": "Type:\nDosage Forms: suspension, tablet\nRoutes of Administration: PO\nCommon Trade Names: Carafate",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Adult_Dosing": {
      "text": "Duodenal ulcer\nActive ulcer treatment: 1g PO 4 times daily x 4-8 weeks\nMaintenance therapy: 1g twice daily",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Duodenal ulcer",
          "url": "https://wikem.org/wiki/Duodenal_ulcer"
        }
      ]
    },
    "Pediatric_Dosing": {
      "text": "Peptic ulcer disease\n: 40-80 mg/kg/day divided q6 hours, maximum 1000mg/dose\nEsophagitis\n3 months-6 years of age: 500mg PO 4 times daily\n>6 years: 1000mg/dose four times daily",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Peptic ulcer disease",
          "url": "https://wikem.org/wiki/Peptic_ulcer_disease"
        }
      ]
    },
    "Special_Populations": {
      "text": "",
      "subsections": {
        "Pregnancy_Rating": {
          "text": "B: Acceptable for use in pregnancy",
          "tables": []
        },
        "Lactation_risk": {
          "text": "Use considered acceptable",
          "tables": []
        },
        "Renal_Dosing": {
          "text": "Use caution in chronic renal failure or dialysis due to absorption of aluminum salts",
          "tables": []
        },
        "Hepatic_Dosing": {
          "text": "No adjustment",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Pregnancy_Rating": {
      "text": "B: Acceptable for use in pregnancy",
      "subsections": {
        "Lactation_risk": {
          "text": "Use considered acceptable",
          "tables": []
        },
        "Renal_Dosing": {
          "text": "Use caution in chronic renal failure or dialysis due to absorption of aluminum salts",
          "tables": []
        },
        "Hepatic_Dosing": {
          "text": "No adjustment",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Lactation_risk": {
      "text": "Use considered acceptable",
      "subsections": {
        "Renal_Dosing": {
          "text": "Use caution in chronic renal failure or dialysis due to absorption of aluminum salts",
          "tables": []
        },
        "Hepatic_Dosing": {
          "text": "No adjustment",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Renal_Dosing": {
      "text": "Use caution in chronic renal failure or dialysis due to absorption of aluminum salts",
      "subsections": {
        "Hepatic_Dosing": {
          "text": "No adjustment",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Hepatic_Dosing": {
      "text": "No adjustment",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Contraindications": {
      "text": "Allergy to class/drug",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Adverse_Reactions": {
      "text": "",
      "subsections": {
        "Serious": {
          "text": "Anaphylaxis\nBronchospasm, laryngeal/pharyngeal/pulmonary edema",
          "tables": []
        },
        "Common": {
          "text": "Constipation",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Serious": {
      "text": "Anaphylaxis\nBronchospasm, laryngeal/pharyngeal/pulmonary edema",
      "subsections": {
        "Common": {
          "text": "Constipation",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Common": {
      "text": "Constipation",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Pharmacology": {
      "text": "Acts locally in GI tract, minimally absorbed\nHalf-life:\nMetabolism: none\nExcretion:",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Mechanism_of_Action": {
      "text": "Binds to form complex with positively charged proteins in exudates, forming a viscous paste-like adhesive substance, which then selectively forms a protective coating that protects gastric lining against peptic acid, pepsin, and bile salts",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "See_Also": {
      "text": "peptic ulcer disease",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "peptic ulcer disease",
          "url": "https://wikem.org/wiki/Peptic_ulcer_disease"
        }
      ]
    },
    "References": {
      "text": "Uptodate",
      "subsections": {},
      "tables": [],
      "links": []
    }
  }
}